ProBiotix Health marks CPHI debut with probiotic-based menopause products that bridge nutraceutical & pharma innovation
ProBiotix Health, a pioneer in advanced probiotic science, will spotlight YourBiotixMH and YourBiotixPMH, its range of probiotic-based menopause formulations, at CPHI Frankfurt, at booth #4.1B62. Designed to support symptom relief and long-term cardiovascular health, ProBiotix has created its YourBiotix formulations to reshape the conversation around menopause, moving the focus from short-term relief to addressing […]
ProBiotix Health focus on groundbreaking probiotic menopause solutions at SupplySide Global, redefining women’s health beyond symptom relief
ProBiotix Health (‘ProBiotix’), a pioneer in advanced probiotic science, will be exhibiting its flagship probiotic strain, LPLDL®, and new menopause support solutions, YourBiotixMH and YourBiotixPMH, at SupplySide Global. The event, being held on October 29-30 in Las Vegas, marks ProBiotix Health’s entry into the US women’s health market. YourBiotixMH and YourBiotixPMH were formulated to reshape […]
ProBiotix Health strengthens APAC market presence with new TopHealth agreement in South Korea
ProBiotix Health Plc (‘ProBiotix’), the life sciences company developing probiotics to support cardiometabolic health, has further strengthened its presence in the APAC market with a new long-term partnership agreement with TopHealth, a leading South Korean consumer products business focused on health and wellness. Under the terms of the partnership, ProBiotix has granted TopHealth exclusive rights […]
ProBiotix Health celebrates robust growth and global expansion in milestone year
ProBiotix Health plc (‘ProBiotix’), the life sciences business developing probiotics to support cardiometabolic health, is celebrating strong performance through 2024, marked by significant geographic expansion and strengthened scientific partnerships. The company reported a 13% increase in net sales to £1.88m, alongside a 15% rise in gross profit. This growth was driven by successful market penetration […]
ProBiotix Health announces new commercial partnership with Ukraine-based Deutsch-Pharm
ProBiotix Health Plc (‘ProBiotix’), a life sciences company developing probiotics to support cardiometabolic health, has strengthened its global footprint with the conclusion of a commercial partnership with the Ukraine-based pharmaceutical distributor, Deutsch-Pharm Lcc (Deutsch Pharm). This partnership will see an initial focus on the Ukrainian market followed by Uzbekistan and other countries in the region, with commercialisation expected […]
ProBiotix Health announces new commercial partnership in Greece with consumer brand specialist Eifron
ProBiotix Health Plc (‘ProBiotix’), a life sciences company developing probiotics to support cardiometabolic health, has strengthened its global footprint by cementing a commercial partnership with Eifron SA (‘Eifron’), a consumer brand specialist based in Greece. As part of the alliance, Eifron will introduce YourBiotixBP, containing ProBiotix’s proprietary IP protected probiotic strain LPLDL®, to its existing […]
ProBiotix Health strengthens global presence With DanCare Chinese distribution deal
ProBiotix Health Plc (‘ProBiotix’), a life sciences company developing probiotics to support cardiometabolic health, has strengthened its global footprint with a new partnership agreement with supplement specialist DanCare for the distribution of its InstaMelt product in China. This strategic move marks a significant step for ProBiotix in penetrating the Chinese health and nutrition market with […]
ProBiotix Health appoints Cellan Davies as new Head of Marketing
ProBiotix Health Plc (‘ProBiotix’), a life sciences company that develops probiotic formulations to support cardiometabolic health has appointed Cellan Davies as its new Head of Marketing to drive forward new innovative marketing strategies and enhance customer acquisition efforts. Davies has previously held a part-time position with ProBiotix Health and comes with more than 10 years […]
ProBiotix Health signs partner agreement with SymbioPharm
ProBiotix Health Plc (‘ProBiotix’), a life sciences company that develops probiotic formulations to support cardiometabolic health, has entered into a new partnership agreement with SymbioPharm that enables the dietary supplement brand to utilise the CholBiome®CH formulation from ProBiotix to target and reduce cholesterol in its branded range of consumer products. SymbioPharm, the pioneering German company specialising […]